The Second Hospital, University of South China Trials

The Second Hospital, University of South China	Welcome, Profile Billing Logout

The Second Hospital, University of South China

Welcome, Profile Billing Logout

0 Trials

2 Trials

Active Trials

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Tan

PREVAIL, NCT05202509 / 2021-005092-39: Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease

Active, not recruiting

9541

Europe, Canada, Japan, US, RoW

Obicetrapib, Placebo

NewAmsterdam Pharma, Monash University

Atherosclerotic Cardiovascular Disease

11/26

NCT06175351: Study to Evaluate the Pharmacokinetic Characteristics, Safety, Tolerability, and Preliminary Efficacy of 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD).

Recruiting

1/2

RoW

9MW1911, Placebo

Mabwell (Shanghai) Bioscience Co., Ltd.

Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

09/25

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites